Trade Summary

1 week ago, Lizzul Paul F., serving as Chief Medical Officer at Anaptysbio, Inc (ANAB), sold 1,500 shares at $50.00 per share, for a total transaction value of $75,000.00. Following this transaction, Lizzul Paul F. now holds 26,967 shares of ANAB.

This sale represents a 5.00% decrease in Lizzul Paul F.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, December 22, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 23, 2025, 1 day after the trade was made.

Anaptysbio, Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.